PRJ1-3024

· Zhuhai Yufan Biotechnologies Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PRJ1-3024, covering 2024-12-11 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors [Phase 1]

See pricing